Skip to main navigation Skip to search Skip to main content

Significance of circulating tumor cells in metastatic triple-negative breast cancer patients within a randomized, phase II trial: TBCRC 019

  • Translational Breast Cancer Research Consortium (TBCRC)

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Significance of circulating tumor cells in metastatic triple-negative breast cancer patients within a randomized, phase II trial: TBCRC 019'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Keyphrases

Immunology and Microbiology